Propanc Biopharma, Inc.
PPCB· Nasdaq
Quarterly figures for Propanc Biopharma, Inc., with source filings when available.
63 quarters. Dec 31, 2010 to Jun 30, 2026. mixed units.
Propanc Biopharma, Inc. has filed its 10-Q within 44 to 51 days of period end across its last 8 quarters. The 10-K runs 87 to 107 days.
Propanc Biopharma, Inc. · CIK 1517681 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q4 2026derived | Jun 30, 2026 | — | Sep 25, 2026 | 87 d | 10-K | — | — | — | |
| Q3 2026 | Mar 31, 2026 | — | May 14, 2026 | 44 d | 10-Q | — | — | -$0.28 | |
| Q2 2026 | Dec 31, 2025 | — | Feb 17, 2026 | 48 d | 10-Q | — | — | -$0.30 | |
| Q1 2026 | Sep 30, 2025 | — | Nov 14, 2025 | 45 d | 10-Q | — | — | -$0.39 | |
| FY 2025 | |||||||||
| Q4 2025derived | Jun 30, 2025 | — | Sep 29, 2025 | 91 d | 10-K | — | — | — | |
| Q3 2025 | Mar 31, 2025 | — | May 15, 2025 | 45 d | 10-Q | ||||
| FY 2024 | |||||||||
| Q4 2024derived | Jun 30, 2024 | — | Sep 30, 2024 | 92 d | 10-K | — | — | — | |
| Q3 2024 | Mar 31, 2024 | — | May 15, 2024 | 45 d | 10-Q | ||||
| FY 2023 | |||||||||
| Q4 2023derived | Jun 30, 2023 | — | Sep 28, 2023 | 90 d | 10-K | — | — | — | |
| Q3 2023 | Mar 31, 2023 | — | May 15, 2023 | 45 d | 10-Q | ||||
| FY 2022 | |||||||||
| Q4 2022derived | Jun 30, 2022 | — | Sep 28, 2022 | 90 d | 10-K | — | — | — | |
| Q3 2022 | Mar 31, 2022 | — | May 16, 2022 | 46 d | 10-Q | ||||
| FY 2021 | |||||||||
| Q4 2021derived | Jun 30, 2021 | — | Sep 28, 2021 | 90 d | 10-K | — | — | — | |
| Q3 2021 | Mar 31, 2021 | — | May 14, 2021 | 44 d | 10-Q | ||||
| FY 2020 | |||||||||
| Q4 2020derived | Jun 30, 2020 | — | Oct 1, 2020 | 93 d | 10-K | — | — | — | |
| Q3 2020 | Mar 31, 2020 | — | May 15, 2020 | 45 d | 10-Q | ||||
| FY 2019 | |||||||||
| Q4 2019derived | Jun 30, 2019 | — | Oct 15, 2019 | 107 d | 10-K | — | — | — | |
| Q3 2019 | Mar 31, 2019 | — | May 15, 2019 | 45 d | 10-Q | ||||
| FY 2018 | |||||||||
| Q4 2018derived | Jun 30, 2018 | — | Sep 17, 2018 | 79 d | 10-K | — | — | — | |
| Q3 2018 | Mar 31, 2018 | — | May 10, 2018 | 40 d | 10-Q | ||||
| FY 2017 | |||||||||
| Q4 2017derived | Jun 30, 2017 | — | Sep 28, 2017 | 90 d | 10-K | — | — | — | |
| Q3 2017 | Mar 31, 2017 | — | May 8, 2017 | 38 d | 10-Q | ||||
| FY 2016 | |||||||||
| Q4 2016derived | Jun 30, 2016 | — | Sep 28, 2016 | 90 d | 10-K | — | — | — | |
| Q3 2016 | Mar 31, 2016 | — | May 16, 2016 | 46 d | 10-Q | ||||
| FY 2015 | |||||||||
| Q4 2015derived | Jun 30, 2015 | — | Sep 30, 2015 | 92 d | 10-K | — | — | — | |
| Q3 2015 | Mar 31, 2015 | — | May 15, 2015 | 45 d | 10-Q | ||||
| FY 2014 | |||||||||
| Q4 2014derived | Jun 30, 2014 | — | Oct 14, 2014 | 106 d | 10-K | — | — | — | |
| Q3 2014 | Mar 31, 2014 | — | May 20, 2014 | 50 d | 10-Q | ||||
| FY 2013 | |||||||||
| Q4 2013derived | Jun 30, 2013 | — | Oct 15, 2013 | 107 d | 10-K | — | — | — | |
| Q3 2013 | Mar 31, 2013 | — | May 20, 2013 | 50 d | 10-Q | ||||
| FY 2012 | |||||||||
| Q4 2012derived | Jun 30, 2012 | — | — | — | — | — | — | — | |
| Q3 2012 | Mar 31, 2012 | — | May 21, 2012 | 51 d | 10-Q | — | — | -$0.04 | |
| FY 2011 | |||||||||
| Q4 2011derived | Jun 30, 2011 | — | — | — | — | — | — | — | |
| Q3 2011 | Mar 31, 2011 | — | — | — | — | — | — | -$0.01 | |
| Q2 2011 | |||||||||
| — |
| — |
| -$12.50 |
| Q2 2025 | Dec 31, 2024 | — | Feb 14, 2025 | 45 d | 10-Q | — | — | -$32.23 |
|---|
| Q1 2025 | Sep 30, 2024 | — | Nov 14, 2024 | 45 d | 10-Q | — | — | -$35.97 |
|---|
| — |
| — |
| -$545.79 |
| Q2 2024 | Dec 31, 2023 | — | Feb 20, 2024 | 51 d | 10-Q | — | — | -$1,559.55 |
|---|
| Q1 2024 | Sep 30, 2023 | — | Nov 14, 2023 | 45 d | 10-Q | — | — | -$0.04 |
|---|
| — |
| — |
| -$0.42 |
| Q2 2023 | Dec 31, 2022 | — | Feb 10, 2023 | 41 d | 10-Q | — | — | -$0.53 |
|---|
| Q1 2023 | Sep 30, 2022 | — | Nov 14, 2022 | 45 d | 10-Q | — | — | -$2.13 |
|---|
| — |
| — |
| — |
| Q2 2022 | Dec 31, 2021 | — | Feb 14, 2022 | 45 d | 10-Q | — | — | -$0.02 |
|---|
| Q1 2022 | Sep 30, 2021 | — | Nov 12, 2021 | 43 d | 10-Q | — | — | -$0.02 |
|---|
| — |
| — |
| -$0.12 |
| Q2 2021 | Dec 31, 2020 | — | Feb 12, 2021 | 43 d | 10-Q | — | — | -$0.45 |
|---|
| Q1 2021 | Sep 30, 2020 | — | Nov 16, 2020 | 47 d | 10-Q | — | — | -$0.71 |
|---|
| — |
| — |
| -$348.75 |
| Q2 2020 | Dec 31, 2019 | — | Feb 14, 2020 | 45 d | 10-Q | — | — | -$1,250.78 |
|---|
| Q1 2020 | Sep 30, 2019 | — | Nov 14, 2019 | 45 d | 10-Q | — | — | -$1.41 |
|---|
| — |
| — |
| -$0.89 |
| Q2 2019 | Dec 31, 2018 | — | Feb 14, 2019 | 45 d | 10-Q | — | — | -$41.33 |
|---|
| Q1 2019 | Sep 30, 2018 | — | Nov 13, 2018 | 44 d | 10-Q | — | — | -$10.00 |
|---|
| — |
| — |
| -$0.06 |
| Q2 2018 | Dec 31, 2017 | — | Feb 9, 2018 | 40 d | 10-Q | — | — | -$0.20 |
|---|
| Q1 2018 | Sep 30, 2017 | — | Nov 9, 2017 | 40 d | 10-Q | — | — | -$0.36 |
|---|
| — |
| — |
| -$0.38 |
| Q2 2017 | Dec 31, 2016 | — | Feb 14, 2017 | 45 d | 10-Q | — | — | -$1.13 |
|---|
| Q1 2017 | Sep 30, 2016 | — | Nov 10, 2016 | 41 d | 10-Q | — | — | -$0.36 |
|---|
| — |
| — |
| -$1.05 |
| Q2 2016 | Dec 31, 2015 | — | Feb 16, 2016 | 47 d | 10-Q | — | — | -$0.01 |
|---|
| Q1 2016 | Sep 30, 2015 | — | Nov 16, 2015 | 47 d | 10-Q | — | — | $0.00 |
|---|
| — |
| — |
| $0.00 |
| Q2 2015 | Dec 31, 2014 | — | Feb 17, 2015 | 48 d | 10-Q | — | — | $0.00 |
|---|
| Q1 2015 | Sep 30, 2014 | — | Nov 19, 2014 | 50 d | 10-Q | — | — | -$0.01 |
|---|
| — |
| — |
| $0.00 |
| Q2 2014 | Dec 31, 2013 | — | Feb 14, 2014 | 45 d | 10-Q | — | — | $0.00 |
|---|
| Q1 2014 | Sep 30, 2013 | — | — | — | — | — | — | -$0.01 |
|---|
| — |
| — |
| $0.00 |
| Q2 2013 | Dec 31, 2012 | — | Feb 20, 2013 | 51 d | 10-Q | — | — | -$0.02 |
|---|
| Q1 2013 | Sep 30, 2012 | — | Nov 19, 2012 | 50 d | 10-Q | — | — | -$0.01 |
|---|
| Q2 2012 | Dec 31, 2011 | — | Feb 21, 2012 | 52 d | 10-Q | — | — | -$0.03 |
|---|
| Q1 2012 | Sep 30, 2011 | — | — | — | — | — | — | -$0.04 |
|---|
| Dec 31, 2010 |
| — |
| — |
| — |
| — |
| — |
| — |
| -$0.01 |